These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pyrbuterol: a new bronchodilator. Phase I-single dose study. Steen SN, Ziment I, Thomas JS. Curr Ther Res Clin Exp; 1974 Oct; 16(10):1077-81. PubMed ID: 4215618 [No Abstract] [Full Text] [Related]
10. Pirbuterol vs. hydroxyzine vs. theophylline vs. placebo in the treatment of bronchial asthma. Brandon ML. Ann Allergy; 1980 Jul; 45(1):8-12. PubMed ID: 7406244 [Abstract] [Full Text] [Related]
11. Long-term oral bronchodilator therapy of asthma with pirbuterol. Burki NK, Diamond L. Clin Pharmacol Ther; 1978 Jul; 24(1):84-9. PubMed ID: 657723 [Abstract] [Full Text] [Related]
18. Evaluation of a new B 2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. II. Oral comparison with ephedrine. Dulfano MJ, Glass P. Curr Ther Res Clin Exp; 1973 Apr; 15(4):150-7. PubMed ID: 4144567 [No Abstract] [Full Text] [Related]
20. Effect of increasing dosage of an inhaled beta-2 specific agonist on pulmonary function, tremor, and cardiovascular indices. Tinkelman DG, Lutz C. Ann Allergy; 1992 Jan; 68(1):23-6. PubMed ID: 1346562 [Abstract] [Full Text] [Related] Page: [Next] [New Search]